Biosensors International - About the company
Biosensors International is an acquired company based in Singapore (Singapore), founded in 1990. It operates as a Products for interventional cardiology and critical care procedures. Biosensors International has raised an undisclosed amount in funding, with last known valuation of $*****. The company has 50 active competitors, including 14 funded and 12 that have exited. Its top competitors include companies like Edwards Lifesciences, InspireMD and Lifetech Scientific Corporation.
Company Details
Biosensors International develops medical devices used in interventional cardiology and critical care procedures. Their product offerings include drug-eluting stents, drug coated stents, bare metal stents and angioplasty catheters for the treatment of coronary artery disease. They also offer stenting and ballooning solutions for peripheral arterial diseases. Biosensors International was acquired by Citic Group in 2015.
- Website
- www.biosensors.com/intl/
Key Metrics
Founded Year
1990
Location
Singapore, Singapore
Stage
Acquired
Latest Funding Round
Last Known Valuation
$***** as on Nov 04, 2015
Ranked
9th among 50 active competitors
Annual Revenue
SGD 50M - 100M as on Dec 31, 2023
Employee Count
507 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by CPE (Nov 04, 2015)
Legal entities associated with Biosensors International
Biosensors International is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BIOSENSORS MEDICAL INDIA PRIVATE LIMITED CIN: U85190PN2019FTC187311 , India, Active | Oct 17, 2019 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | - | |
BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE. LTD. UEN: 200602332R , Singapore, Active | Dec 31, 1989 | SGD 50M - 100M (As on Dec 31, 2023) | - |
Biosensors International's acquisition details
Click here to take a look at Biosensors International's acquisition in detail
Sign up to download Biosensors International's company profile
Biosensors International's funding and investors
Biosensors International has raised funding over 1 round. Its latest funding round was a Post IPO round on Jan 05, 2007 for $*****. 3 investors participated in its latest round. Biosensors International has 10 institutional investors.
Here is the list of recent funding rounds of Biosensors International:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 05, 2007 | 3974184 | Post IPO | 4039598 | 4305882 | 3618666 | 8391972 |
View details of Biosensors International's funding rounds and investors
Biosensors International's founders and board of directors
Founder? Claim ProfileBiosensors International's employee count trend
Biosensors International has 507 employees as of Aug 26. Here is Biosensors International's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biosensors International's Competitors and alternates
Top competitors of Biosensors International include Edwards Lifesciences, InspireMD and Lifetech Scientific Corporation. Here is the list of Top 10 competitors of Biosensors International, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Edwards Lifesciences 1958, Irvine (United States), Public | Developer of medical devices for structural heart disease | - | 66/100 | |
2nd | InspireMD 2005, Boston (United States), Public | Stents integrated with a bio-stable mesh | $34M | 63/100 | |
3rd | Lifetech Scientific Corporation 1999, Shenzhen (China), Public | Interventional medical devices to treat cardiovascular and peripheral vascular diseases. | $66.2M | 59/100 | |
4th | REVA Medical 1998, San Diego (United States), Public | Developer of Balloon-expandable and bioresorbable drug-eluting stent | $42M | 58/100 | |
5th | S3V Vascular Technologies 2011, Mysuru (India), Series B | Developer of cardiovascular surgical and critical care devices | $41.9M | 55/100 | |
6th | Provider of stent graft endovascular solution for aortic aneurysms | $25M | 52/100 | ||
7th | Vesper Medical 2016, Wayne (United States), Acquired | Provider of venous stent system | $52.5M | 51/100 | |
8th | Peytant Solutions 2008, Plymouth (United States), Seed | Developer of a regenerative medical device for the treatment of luminal diseases | $5.59M | - | 48/100 |
9th | Biosensors International 1990, Singapore (Singapore), Acquired | Products for interventional cardiology and critical care procedures | - | 48/100 | |
10th | PECA Labs 2011, Pittsburgh (United States), Series B | Developer of pediatric cardiac surgical devices | $22.6M | 48/100 |
Looking for more details on Biosensors International's competitors? Click here to see the top ones
Biosensors International's Investments and acquisitions
Biosensors International has made 2 investments in GoodParentInc and Kiddo Health and acquired Spectrum Dynamics.Here is the list of these investments and acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 14, 2016 | Investments | 2008 | Palo Alto (United States) | |
2016 | Investments | 2016 | San Francisco (United States) | |
May 13, 2013 | Acquisition | 2000 | Morges (Switzerland) |
Reports related to Biosensors International
Here is the latest report on Biosensors International's sector:
News related to Biosensors International
Media has covered Biosensors International for 1 event in last 1 year.
•
WiemsPro Secures €240,000 Enisa Loan for Sensorized Training Suit.El Referente•Dec 01, 2025•Wiemspro, Biosensors International, Chicago Transit Authority
•
Biotech Startup Monod Bio Collects $25 Million Seed FinancingThe Wall Street Journal•Aug 15, 2022•Monod, monodbio.com, Matrix Partners India, Global Health Investment and 6 others
•
Blue Sail Medical and Biosensors International enter the Structural Heart market with the acquisition of Switzerland based NVT AG.PR Newswire•Sep 23, 2019•Blue Sail, Biosensors International, New Valve
•
Heart Stent Market Forecast & Opportunities 2019: Abbott, Medtronic, Boston Scientific, Biosensor InternationalDigital Journal•Mar 13, 2019•Biosensors International, Boston Scientific, Medtronic, Abbott
•
Next-Generation Drug-Eluting Stent Market Emerging Top Key Vendors to Watch - Abbott Laboratories, Biosensors, Medtronic, Sorin Group, SMT, and Terumo by 2025Digital Journal•Feb 21, 2019•Biosensors International, Medtronic
•
Global Enteral Stents Market Insights 2018 : Abbott Vascular, B. Braun Melsungen, Biosensors International, Boston Scientifictalkdailynews.com•Nov 22, 2018•vascular.abbott, BKK B. Braun Melsungen AG, Biosensors International, Boston Scientific
•
Biosensors Market Overview with Detailed Analysis, Competitive landscape Forecast to 2024Algos Online•Nov 15, 2018•Abbott, Bio Rad, Biosensors International
•
Global Enteral Stents Market Outlook 2018: Abbott Vascular, B. Braun Melsungen, Biosensors International, Boston Scientifictruthweek.com•Nov 04, 2018•B Braun, Abbott, Biosensors International, Boston Scientific
•
Blue Sail raises RMB1.837 bln to purchase Biosensors International GroupXinhua Finance Agency•Sep 06, 2018•Biosensors International, Blue Sail
•
Global Bare Metal Stents Market Analysis Report 2018: Abbott Vascular, Medtronic, Boston Scientific, Biosensors Internationaltruthweek.com•Aug 01, 2018•vascular.abbott, Biosensors International, Boston Scientific, Medtronic
Are you a Founder ?
FAQs about Biosensors International
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company